Skip to main content
Download PDF

Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety

Journal of Pharmaceutical Policy and Practice volume 13, Article number: 30 (2020) Cite this article

The Original Article was published on 18 May 2020

Correction to: J Pharm Policy Pract (2020) 13:18

https://doi.org/10.1186/s40545-020-00219-1

Following publication of the original article [1], we notified of a mistake in the article’s title.

Correct article title:

Amid COVID-19: the importance of developing a positive reporting culture of adverse drug reaction (ADR) and medical device incident (MDI) for Global Health and public safety

Reference

  1. Elbeddini A, et al. Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J Pharm Policy Pract. 2020;13:18. https://doi.org/10.1186/s40545-020-00219-1.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Winchester District Memorial Hospital (WDMH), 556 Louise St, Winchester, ON, K0C2K0, Canada

    Ali Elbeddini & Stephanie Lee

  2. Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, M5S 3M2, Canada

    Aniko Yeats

Authors
  1. Ali Elbeddini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aniko Yeats
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Elbeddini.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elbeddini, A., Yeats, A. & Lee, S. Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J of Pharm Policy and Pract 13, 30 (2020). https://doi.org/10.1186/s40545-020-00231-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40545-020-00231-5

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us